RE: Patent12 Jun 2018 20:36
Does it need another RNS ? Scancell has informed the market that as of tomorrow its granted. Since that info was released a steady buying pressure as occurred, What i would say once the Ichor deal has been confirmed and the IND submitted any negativity abates completely .. after all Modi1 is in manufacture, so cannot speed up that process, which only leaves the delivery method of SCIB2 .... which is of great interest.
we then have the run in to the Grand Challenge and a potential deal with TCR BioNtech at year end or sooner.
again read the OXB deal RNS .. it has comparable's with SCIB1 and its mark 2 version
C7 i won't reply to you, as your post is hypocritical, as your inciting an argument while complaining about them.
as your not the chief whip of the conservative party or a dictator, how i post, what i post, has nothing to do with you, unless you wish to challenge the discussion or join the debate, so sadly yet again your attempts to manipulate the BB has fallen on my deaf ears.